FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313331954> ?p ?o ?g. }

• W4313331954 endingPage "4243" @default.
• W4313331954 startingPage "4236" @default.
• W4313331954 abstract "Abstract The immunomodulatory drug thalidomide has been shown to be clinically useful in a number of situations due to its ability to inhibit TNF-α synthesis. However, its use is restricted by potentially serious side effects, including teratogenicity and neuorotoxicity; furthermore, insolubility may present problems in terms of systemic bioavailability. Recently, structural modifications of thalidomide have been designed enabling greatly enhanced anti-TNF-α activity in LPS-treated mice. In contrast to thalidomide (LPS-induced TNF-α IC50 ∼200 μM in DMSO) and other analogs tested, one of these compounds, CC-3052 (IC50 ∼1 μM in water), is water soluble. Furthermore, this analog exhibits increased stability in human plasma (t1/2 ∼17.5 vs 1.5 h for thalidomide) and appears to be nontoxic, nonmutagenic, and nonteratogenic. At pharmacologically active levels, cellular proliferation and LPS-induced IL-6 mRNA and IL-12p40 mRNA (as well as IL-1β and IL-6 protein levels) in whole blood cultures were not affected; apparent inhibition of NK activity by CC-3052 was reversed upon addition of exogenous rTNF-α. In addition, IL-10 mRNA and protein levels were increased. These properties are consistent with results indicating inhibition of phosphodiesterase type IV activity by CC-3052. Furthermore, CC-3052 did not increase the degradation rate of macrophage TNF-α transcripts nor inhibit LPS-induced primary macrophage NF-κB activation. Taken together, the potency of selective TNF-α inhibition, water solubility, and increased plasma stability make CC-3052 an excellent candidate for further development and clinical evaluation for the treatment of TNF-α-mediated disease." @default.
• W4313331954 created "2023-01-06" @default.
• W4313331954 creator A5025381775 @default.
• W4313331954 creator A5029522995 @default.
• W4313331954 creator A5032165288 @default.
• W4313331954 creator A5037701750 @default.
• W4313331954 creator A5043420360 @default.
• W4313331954 creator A5047574164 @default.
• W4313331954 creator A5067606220 @default.
• W4313331954 creator A5078883724 @default.
• W4313331954 creator A5086691404 @default.
• W4313331954 date "1998-10-15" @default.
• W4313331954 modified "2023-10-02" @default.
• W4313331954 title "CC-3052: A Water-Soluble Analog of Thalidomide and Potent Inhibitor of Activation-Induced TNF-α Production" @default.
• W4313331954 cites W1529226217 @default.
• W4313331954 cites W1750957663 @default.
• W4313331954 cites W1971685694 @default.
• W4313331954 cites W1974520996 @default.
• W4313331954 cites W1993594765 @default.
• W4313331954 cites W2002527035 @default.
• W4313331954 cites W2009334762 @default.
• W4313331954 cites W2013045129 @default.
• W4313331954 cites W2014085694 @default.
• W4313331954 cites W2018948406 @default.
• W4313331954 cites W2019047495 @default.
• W4313331954 cites W2048113128 @default.
• W4313331954 cites W2060662281 @default.
• W4313331954 cites W2067679507 @default.
• W4313331954 cites W2074785439 @default.
• W4313331954 cites W2080532845 @default.
• W4313331954 cites W2088704512 @default.
• W4313331954 cites W2112583269 @default.
• W4313331954 cites W2122596233 @default.
• W4313331954 cites W2129539691 @default.
• W4313331954 cites W2142273705 @default.
• W4313331954 cites W2159746652 @default.
• W4313331954 cites W2162559503 @default.
• W4313331954 cites W2339981418 @default.
• W4313331954 cites W2490791339 @default.
• W4313331954 cites W4299410280 @default.
• W4313331954 cites W9610411 @default.
• W4313331954 doi "https://doi.org/10.4049/jimmunol.161.8.4236" @default.
• W4313331954 hasPublicationYear "1998" @default.
• W4313331954 type Work @default.
• W4313331954 citedByCount "44" @default.
• W4313331954 countsByYear W43133319542012 @default.
• W4313331954 countsByYear W43133319542013 @default.
• W4313331954 countsByYear W43133319542014 @default.
• W4313331954 countsByYear W43133319542015 @default.
• W4313331954 countsByYear W43133319542017 @default.
• W4313331954 countsByYear W43133319542019 @default.
• W4313331954 countsByYear W43133319542023 @default.
• W4313331954 crossrefType "journal-article" @default.
• W4313331954 hasAuthorship W4313331954A5025381775 @default.
• W4313331954 hasAuthorship W4313331954A5029522995 @default.
• W4313331954 hasAuthorship W4313331954A5032165288 @default.
• W4313331954 hasAuthorship W4313331954A5037701750 @default.
• W4313331954 hasAuthorship W4313331954A5043420360 @default.
• W4313331954 hasAuthorship W4313331954A5047574164 @default.
• W4313331954 hasAuthorship W4313331954A5067606220 @default.
• W4313331954 hasAuthorship W4313331954A5078883724 @default.
• W4313331954 hasAuthorship W4313331954A5086691404 @default.
• W4313331954 hasBestOaLocation W43133319541 @default.
• W4313331954 hasConcept C104317684 @default.
• W4313331954 hasConcept C105580179 @default.
• W4313331954 hasConcept C134018914 @default.
• W4313331954 hasConcept C17991360 @default.
• W4313331954 hasConcept C181389837 @default.
• W4313331954 hasConcept C185592680 @default.
• W4313331954 hasConcept C202751555 @default.
• W4313331954 hasConcept C203014093 @default.
• W4313331954 hasConcept C2776364478 @default.
• W4313331954 hasConcept C2777752497 @default.
• W4313331954 hasConcept C2778690821 @default.
• W4313331954 hasConcept C2779609412 @default.
• W4313331954 hasConcept C55493867 @default.
• W4313331954 hasConcept C57992300 @default.
• W4313331954 hasConcept C86803240 @default.
• W4313331954 hasConcept C98274493 @default.
• W4313331954 hasConceptScore W4313331954C104317684 @default.
• W4313331954 hasConceptScore W4313331954C105580179 @default.
• W4313331954 hasConceptScore W4313331954C134018914 @default.
• W4313331954 hasConceptScore W4313331954C17991360 @default.
• W4313331954 hasConceptScore W4313331954C181389837 @default.
• W4313331954 hasConceptScore W4313331954C185592680 @default.
• W4313331954 hasConceptScore W4313331954C202751555 @default.
• W4313331954 hasConceptScore W4313331954C203014093 @default.
• W4313331954 hasConceptScore W4313331954C2776364478 @default.
• W4313331954 hasConceptScore W4313331954C2777752497 @default.
• W4313331954 hasConceptScore W4313331954C2778690821 @default.
• W4313331954 hasConceptScore W4313331954C2779609412 @default.
• W4313331954 hasConceptScore W4313331954C55493867 @default.
• W4313331954 hasConceptScore W4313331954C57992300 @default.
• W4313331954 hasConceptScore W4313331954C86803240 @default.
• W4313331954 hasConceptScore W4313331954C98274493 @default.
• W4313331954 hasIssue "8" @default.
• W4313331954 hasLocation W43133319541 @default.
• W4313331954 hasOpenAccess W4313331954 @default.

• next